PRESENTING THE MACEDONIAN NUCLEAR MEDICINE EXPERIENCE AT THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ANNUAL MEETING 2026
DOI:
https://doi.org/10.67214/2zv6a630Downloads
References
1. Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI 2026 annual meeting highlights transformative advances in clinical practice and research [Internet]. Reston (VA): Society of Nuclear Medicine and Molecular Imaging; 2026 [cited 2026 Jul 17]. Available from: SNMMI 2026 Annual Meeting Highlights.
2. Tasevski S, Manevska N, Todorova - Stefanovski D et al. Predicting first-line immunochemotherapy outcome in Diffuse Large B-Cell Lymphoma patients using 18F-FDG PET/CT parameters. Journal of Nuclear Medicine. 2026;67(1):261143.
Downloads
Published
Data Availability Statement
The abstract of my poster presented at the SNMMI Annual Meeting 2026 can be also found here:
https://jnm.snmjournals.org/content/67/supplement_1/261143
Issue
Section
License
Copyright (c) 2026 Slavko Tasevski (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work and grant the Macedonian Journal of Anaesthesia the right of first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors are permitted to enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of the work, provided that its initial publication in this journal is acknowledged.
